Ledger.Open graph →
SEC Form D · Amendment · filed December 29, 2017

Twist Bioscience Corp

Offering
$75.0M
Sold
$74.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Paul M. Conley · San Francisco, CADirectorBill M. Peck · San Francisco, CAExecWilliam M. Banyai · San Francisco, CAExec · DirectorFred M. Craves · San Francisco, CADirectorEmily M. Leproust · San Francisco, CAExec · DirectorBob M. Ragusa · San Francisco, CADirectorRob M. Chess · San Francisco, CADirectorKeith M. Crandell · San Francisco, CADirectorJoseph M. Niehaus · San Francisco, CADirectorSam Liebman · New York, NYDirectorBob Nelson · Frisco, TXDirectorJoe P. Nemeth · Redwood City, CADirectorMichael J. Fourticq, Senior · Houston, TXExec · DirectorWilliam N. Anderson · Houston, TXExec · DirectorBritton L. Brown · Dallas, TXDirectorPeter H. Huizenga · Oak Brook, ILExecMark G. Hilderbrand · San Francisco, CADirectorBarry D. Reynolds · San Francisco, CADirectorLouis A. La Luna · Jamison, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗